View of the ECOSOC chamber during the Ebola impact discussion 12/5/14. The ears belong to me (on the left) and Dr. Melanie Walker of the World Bank (on the right) On December 5, the United Nations’ Economic and Social Council (ECOSOC) hosted its first meeting on the Ebola epidemic’s long-run implications on development in the affected countries.
Author Archives: CGDev
Last September, we released a report on how the Global Fund could get more health for its money. In it, we offered several concrete suggestions for improvements in several different value-for-money domains, all with an eye toward maximizing the health impact of every dollar spent. A lot can change in a year
This is a joint post with Anit Mukherjee. Related Research Intergovernmental Fiscal Transfers for Health: Overview Framework and Lessons Learned Working Group on Fiscal Transfers for Health In his early days as India’s new prime minister, Narendra Modi has shown remarkable leadership in all sectors, including health, for which he’s articulated his vision to create a Swasth Bharat, a Healthy India.
In the debates over how best to bring electricity to the billion-plus poor people who live every day without it, a common refrain is that we can replicate the telecommunications leapfrog with energy too. It’s an attractive notion. Instead of building telephone landlines, billions of poor people jumped right to mobile phones. Why not just do the same with electricity and, instead of building a grid and big dirty power plants, just go right to off-grid solar? Yet “the supposed analogy between cell phones and distributed solar is misplaced” argues UC Berkeley’s Catherine Wolfram because of (1) cost, (2) benefits of centralized networks, (3) actual development goals, and (4) quality.
The Obama Administration has requested $6.18 billion in emergency funding to fight and contain Ebola. The ask is now in the hands of Congress, but given that Ebola incidence seems to be on the decline in many (not all) districts in West Africa, some leaders are losing steam on the response. But sustained support to fight the current Ebola outbreak is still essential
In the big federal countries where global disease burden is concentrated, most public money for health isn’t ultimately spent by the national ministry of health, the traditional counterpart for global health funders and technical agencies. Instead, most money is programmed and spent subnationally (see figure 1).
This is a joint post with Prashant Yadav, University of Michigan The most valuable currency in global health programs today is accurate and reliable data, but such data—abundant in rich countries—does not exist for most low-income and lower-middle-income countries. And without data on past consumption and unmet needs, program planners and global financiers cannot budget appropriately, pharmaceutical and vaccine companies cannot plan investments, and it is harder to understand how programs are performing and how patients’ needs are changing over time. In OECD countries like the United States, Japan, and those of the European Union, organizations such as IMS Health collect data from a wide array of data sources throughout the health-care delivery chain
In November the World Health Organization will select its next regional director for Africa. As we wrote in a previous blog, this position is not posted publicly and is without an independent mechanism in place to recommend, interview, and evaluate the best qualified candidates.
This is a joint post with David Bryden from RESULTS. Register for our upcoming event: Challenges and Opportunities in the Fight against Drug-Resistant Tuberculosis: Lessons from IOM Workshops Read the rest of CGD’s work on Ebola here.
In November, the World Health Organization will select its next regional director for Africa. As we wrote in a previous blog, this position is not posted publicly and has no independent mechanism in place to recommend, interview, and evaluate the best qualified candidates. We invited each candidate to use the Center’s platform to discuss his or her vision for the future of the WHO Regional Office for Africa (WHO AFRO), how he or she sees current challenges, and why he or she is best suited for the position.
Like others, we’ve written lots about Ebola over the past weeks: the insufficient funding and effort to the response in West Africa, the importance of well-qualified leadership at WHO, the role of health systems in disease response, the futility of travel bans, among others. It’s rare that global health issues are so continuously in the public debate. Yet Ebola has also led to heroic overstatement as well
How much is actually being spent on Ebola by donor governments, organizations, and private individuals? The short answer is that we don’t really know.
Momentum seems to be building on Capitol Hill for some kind of West African travel ban as an anti-Ebola measure. It sounds like a simple solution. But here’s why a travel ban is pointless—or could even make us less safe. Zero direct flights. There are no direct flights between the US and the three affected countries.